David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge University Press (2007)
Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain ignorant of the core issues and are ill-prepared to understand pharmaceutical industry promotion. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry
|Keywords||Physicians Professional ethics Pharmaceutical industry Moral and ethical aspects Drugs Marketing Advertising Drugs Physicians ethics Advertising Drug Industry ethics Gift Giving ethics|
|Categories||categorize this paper)|
|Buy the book||$1.99 used (96% off) $19.97 new (56% off) $40.03 direct from Amazon (12% off) Amazon page|
|Call number||R727.5.J35 2007|
|ISBN(s)||9780521868648 0521688663 9780521688666|
|Through your library||Configure|
Similar books and articles
Edward R. Balotsky (2009). Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries. [REVIEW] Journal of Business Ethics 84 (1):75 - 88.
Włodzimierz Kubiak (2005). Medicine and Pharmacy — Facts and Myths About the Development of an Innovative Pharmaceutical Industry in Poland. Science and Engineering Ethics 11 (1):41-51.
Marc A. Rodwin (2010). Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal. Journal of Law, Medicine and Ethics 38 (4):807-815.
Richard T. de George (2005). Intellectual Property and Pharmaceutical Drugs. Business Ethics Quarterly 15 (4):549-575.
R. Stephen Parker & Charles E. Pettijohn (2003). Ethical Considerations in the Use of Direct-to-Consumer Advertising and Pharmaceutical Promotions: The Impact on Pharmaceutical Sales and Physicians. [REVIEW] Journal of Business Ethics 48 (3):279-290.
Added to index2009-01-28
Total downloads14 ( #93,475 of 1,004,651 )
Recent downloads (6 months)1 ( #64,617 of 1,004,651 )
How can I increase my downloads?